Addington, J. & Adding ton, D. (1998) Effect of substance misuse in early psychosis. British Journal of Psychiatry, 172 (suppl. 33), 134–136.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.
Andreasen, N. (1990) Methods for assessing positive and negative symptoms. In Schizophrenia: Positive and Negative Symptoms and Syndromes. Modern Problems in Pharmacopsychiatry (ed. Andreasen, N.), pp. 73–85. Basel: Karger.
Asberg, M., Montgomery, S. A., Perris, C., et al (1978) A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica Supplementum, 271, 5–27
Barnes, T. R. E., Hutton, S. B., Chapman, M. J., et al (2000) West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. British Journal of Psychiatry, 177, 207–211.
Birchwood, M., Smith, J., Cochrane, R., et al (1990) The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry, 157, 853–859.
Blanchard, J. J., Brown, S. A., Horan, W. P., et al (2000) Substance use disorders in schizophrenia: review, integration and a proposed model. Clinical Psychology Review, 20, 207–234.
Brunette, M. F., Mueser, K. T., Xie, H., et al (1997) Relationships between symptoms of schizophrenia and substance abuse. Journal of Nervous and Mental Disease, 185, 13–20.
Cantor-Graee, E., Nordstr⊘m, L. G. & McNeil, T. F. (2001) Substance abuse in schizophrenia: areview of the literature and a study of correlates in Sweden. Schizophrenia Research, 48, 69–82.
Caspari, D. (1999) Cannabis and schizophrenia: results of a follow-up study. European Archives of Psychiatry and Clinical Neuroscience, 249, 45–49.
Condren, R. M., O'Connor, J. & Browne, R. (2001) Prevalence and patterns of substance misuse in schizophrenia. A catchment area case–control study. Psychiatric Bulletin, 25, 17–20.
Degenhardt, L., Hall, W. & Lynskey, M. (2003) Tessttiing hypotheses about the relationship between cannabis use and psychosis. Drug and Alcohol Dependence, 71, 37–48.
DeLeon, J., Tracy, J. & McCann, E. (2002) Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophrenia Research, 56, 55–65.
Drake, R. E. & Brunette, M. F. (1998) Complications of severe mental illness related to alcohol and other drug disorders. In Recent Developments in Alcoholism (ed. Galanter, M.), pp. 285–299. New York: Plenum.
Duke, P. J., Pantelis, C. & Barnes, T. R. (1994) South Westminster schizophrenia survey. Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. British Journal of Psychiatry, 164, 630–636.
Duke, P. J., Pantelis, C., McPhillips, M. A., et al (2001) Comorbid non-alcohol substance misuse among people with schizophrenia. Epidemiological study in central London. British Journal of Psychiatry, 179, 509–513.
Guy, W. (ed.) (1976) Clinical Global Impression. In: ECDEU Assessment Manual for Psychopharmacology (revised), pp. 217–221. Rockville, MD: National Institute of Mental Health.
Hambrecht, M. & Hafner, H. (1996) Substance abuse and the onset of schizophrenia. Biological Psychiatry, 40, 1155–1163.
Hambrecht, M. & Hafner, H. (2000) Cannabis, vulnerability and the onset of schizophrenia: an epidemiological perspective. Australian and New Zealand Journal of Psychiatry, 34, 468–475.
Henquet, C., Krabbendam, L., Spauwen, J., et al (2005) Prospective cohort study of cannabis use, predisposition for psychosis and psychotic symptoms in young people. BMJ, 330, 11.
Hutton, S. B., Puri, B. K., Duncan, L.-J., et al (1998) Executive function in first-episode schizophrenia. Psychological Medicine, 28, 463–473.
Jeste, D. V., Gladsjo, J. A., Lindamer, L. A., et al (1996) Medical comorbidity in schizophrenia. Schizophrenia Bulletin, 22, 413–430.
Joyce, E. M., Hutton, S. B., Robbins, T. W., et al (2002) Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis. The West London Study. British Journal of Psychiatry, 181 (suppl. 43), s38–s44.
Joyce, E. M., Hutton, S. B., Mutsatsa, S. H., et al (2005) Cognitive heterogeneityin first-episode schizophrenia. British Journal of Psychiatry, 187, 516–522.
Kavanagh, D. J., McGrath, J., Saunders, J. B., et al (2002) Substance misuse in patients with schizophrenia: epidemiology and management. Drugs, 62, 743–755.
Kavanagh, D. J., Waghorn, G., Jenner, L., et al (2004) Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophrenia Research, 66, 115–124.
Larsen, T. K., McGlashan, T. H., Johannessen, J. O., et al (2001) Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatment. American Journal of Psychiatry, 158, 1917–1919.
Linszen, D. H., Dingemans, P. M. & Lenoir, M. E. (1994) Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry, 51, 273–279.
Loebel, A. D., Lieberman, J. A., Alvir, J. M. J., et al (1992) Duration of psychosis and outcome in firstepisode schizophrenia. American Journal of Psychiatry, 149, 1183–1188.
Mastrigt, S. V., Addington, J. & Addington, D. (2004) Substance misuse at presentation to an early psychosis program. Social Psychiatry and Psychiatric Epidemiology, 39, 69–72.
Missar, C., Gold, J., Goldberg, T. (1994) WAIIS–R short forms in chronic schizophrenia. Schizophrenia Research, 12, 247–250.
Montgomery, S. A. & Asberg, M. (1979) Anew depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389.
Mutsatsa, S., Joyce, E. M., Hutton, S., et al (2003) Clinical correlates of early medication compliance: the West London First Episode Schizophrenia Study. Acta Psychiatrica Scandinavica, 108, 439–446.
Nelson, H. E. (1991) The National Adult Reading Test (NART), Second Version. Test Manual. Windsor: NFER–Nelson.
Norman, R. M. G. & Malla, A. K. (2002) Examining adherence to medication and substance use as possible confounds of duration of untreated psychosis. Journal of Nervous and Mental Disease, 190, 331–334.
Olfson, M., Mechanic, D., Hansell, S., et al (2000) Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services, 51, 216–222.
Pencer, A. & Addington, J. (2003) Substance use and cognition in early psychosis. Journal of Psychiatry and Neuroscience, 28, 48–54.
Rabinowitz, J., Bromet, E. J., Lavelle, J., et al (1998) Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychological Medicine, 28, 1411–1419.
Sahakian, B. & Owen, A. (1992) Computerised assessment in neuropsychiatry using CANTAB. Journal of the Royal Society of Medicine, 85, 399–402.
Salyers, M. P. & Mueser, K. T. (2001) Social functioning, psychopathology and medication side-effects in relation to substance use and abuse in schizophrenia. Schizophrenia Research, 48, 109–123.
Semple, D. M., McIntosh, A. M. & Lawrie, S. M. (2005) Cannabis as a risk factor for psychosis: systematic review. Journal of Psychopharmacology, 19, 187–194.
Sevy, S., Robinson, D. G., Solloway, S., et al (2001) Correlates of substance misusein patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatrica Scandinavica, 104, 367–374.
Shallice, T. (1982) Specific impairments of planning. Philosophical Transactions of the Royal Society of London Series B: Biological Sciences, 298, 199–209.
Smit, F., Bolier, L. & Cuijpers, P. (2004) Cannabis use and the risk of later schizophrenia: a review. Addiction, 99, 425–430.
Sobell, L. C., Agrawal, S., Annis, H., et al (2001) Cross-cultural evaluation of two drinking assessment instruments: alcohol time-line follow-back and inventory of drinking situations. Substance Use and Misuse, 36, 313–331.
Sorbara, F., Liraud, F., Assens, F., et al (2003) Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. Schizophrenia Research, 18, 133–136.
Tsapakis, E.-M., Guillin, O. & Murray, R. M. (2003) Does dopamine sensitization underlie the association between schizophrenia and drug abuse?
Current Opinion in Psychiatry, 16 (suppl. 2), 45–52.
Veen, N. D., Selten, J.-P., van der Tweel, I., et al (2004) Cannabis use and age at onset of schizophrenia. American Journal of Psychiatry, 161, 501–506.
Weaver, T., Madden, P., Charles, V., et al (2003) Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry, 183, 304–313.
Weiden, P., Rapkin, B., Mott, T., et al (1994) Rating of Medication Influences (ROMI) scale in schizophrenia. Schizophrenia Bulletin, 20, 297–310.